Hematology · Leukemia

Chronic Lymphocytic Leukemia

USMLE2PANCE
7

Bets

The facts most likely to be tested

1

Chronic Lymphocytic Leukemia is the most common leukemia in adults in Western countries, typically presenting in asymptomatic elderly patients with isolated lymphocytosis.

Confidence:
2

Peripheral blood smears characteristically demonstrate smudge cells (or basket cells), which are fragile, disrupted lymphocytes resulting from the slide preparation process.

Confidence:
3

Flow cytometry is the diagnostic gold standard, revealing a clonal population of B-cells expressing CD5, CD19, CD20, and CD23 surface markers.

Confidence:
4

Patients frequently develop autoimmune hemolytic anemia (AIHA) or immune thrombocytopenia (ITP) due to the production of autoantibodies by the malignant B-cell clone.

Confidence:
5

Transformation to an aggressive high-grade lymphoma, known as Richter transformation, should be suspected in patients presenting with rapidly enlarging lymph nodes, fever, and weight loss.

Confidence:
6

Clinical staging is determined by the Rai staging system, which relies on the presence of lymphadenopathy, hepatosplenomegaly, anemia, and thrombocytopenia.

Confidence:
7

Asymptomatic patients with early-stage disease are managed with observation (watch and wait), as early treatment does not improve overall survival.

Confidence:

Vignette unlocked

A 72-year-old male presents for a routine physical examination and is found to have a white blood cell count of 45,000/µL. He reports no fevers, night sweats, or unintentional weight loss. Physical examination reveals bilateral cervical and axillary lymphadenopathy and a palpable spleen tip. Peripheral blood smear shows a predominance of mature-appearing lymphocytes and numerous smudge cells. Flow cytometry confirms the presence of CD5+ and CD23+ B-cells.

What is the most appropriate initial management for this patient?

+Reveal answer

Observation (watch and wait)

The patient has asymptomatic, early-stage CLL (Rai stage I/II); per the standard of care, asymptomatic patients do not require immediate chemotherapy and are monitored for disease progression.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Most common leukemia in Western adults; median age of diagnosis is 70 years.

Clinical Manifestations

Often asymptomatic (incidental lymphocytosis); classic B-symptoms and lymphadenopathy.

Diagnosis

Flow cytometry showing clonal B-cells with CD5 and CD19 co-expression.

Treatment

Observation for asymptomatic; Ibrutinib or Venetoclax for symptomatic disease.

Prognosis

Transformation to aggressive lymphoma known as Richter transformation.

Full handout

Epidemiology & Etiology

Predominantly affects the elderly with a male-to-female ratio of 2:1. It is a malignancy of mature B-lymphocytes that fail to undergo apoptosis. No known strong association with radiation or chemical exposure.

Pertinent Anatomy

Involves the bone marrow, peripheral blood, and lymphoid tissues. Splenomegaly and hepatomegaly occur due to massive infiltration of malignant lymphocytes.

Pathophysiology

Characterized by the accumulation of incompetent, monoclonal B-cells in the G0 phase of the cell cycle. These cells express CD5, CD19, CD20, and CD23. Impaired humoral immunity leads to hypogammaglobulinemia and increased infection risk.

Clinical Manifestations

Most patients are diagnosed via routine CBC showing isolated lymphocytosis. Physical exam reveals painless lymphadenopathy and splenomegaly. B-symptoms (fever, night sweats, weight loss) indicate advanced disease. Autoimmune hemolytic anemia (AIHA) is a common paraneoplastic complication.

Diagnosis

The gold standard is flow cytometry of peripheral blood. Peripheral smear classically shows smudge cells (fragile lymphocytes). Diagnostic threshold requires a sustained absolute lymphocyte count > 5,000/µL for at least 3 months.

Treatment

Asymptomatic patients are managed with observation. Symptomatic patients (e.g., cytopenias, bulky nodes) receive Ibrutinib (BTK inhibitor) or Venetoclax. Avoid chemotherapy in patients with significant comorbidities. Monitor for tumor lysis syndrome during initiation of therapy.

Prognosis

Disease progression is monitored via the Rai staging system. Patients are at high risk for recurrent infections due to hypogammaglobulinemia. Watch for Richter transformation, which is the development of high-grade diffuse large B-cell lymphoma.

Differential Diagnosis

Hairy Cell Leukemia: TRAP stain positive and pancytopenia

Follicular Lymphoma: Nodal architecture effacement on biopsy

Mantle Cell Lymphoma: Cyclin D1 overexpression

Viral Lymphocytosis: Transient, usually EBV or CMV

Acute Lymphoblastic Leukemia: Blasts on smear and rapid onset